What ONCOLYTICS BIOTECH INC's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 14 |
| Sells | 0 | 0 |
| Total trades | 0 | 14 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 404,282 |
| Disposed | 0 | 0 |
| Net activity | +0 | +404,282 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Kelly Jared | Chief Executive Officer | Mar 12 | Open-market buy · P | +5,050 | $0.96 | +$4.85K | 114,050 |
| Parsons James T. | Director | Mar 11 | Open-market buy · P | +10,000 | $1.03 | +$10.3K | 41,849 |
| Brown Deborah Margaret | Director | Feb 12 | Open-market buy · P | +25,000 | $0.85 | +$21.2K | 109,851 |
| Heineman Thomas Charles | Chief Medical Officer | Feb 12 | Open-market buy · P | +12,132 | $0.83 | +$10K | 282,818 |
| Andrews Patricia S | Director | Feb 12 | Open-market buy · P | +35,400 | $0.86 | +$30.3K | 78,128 |
| Hagerman Allison | VP, Product Development | Feb 12 | Open-market buy · P | +10,000 | $0.83 | +$8.3K | 115,059 |
| Kelly Jared | Chief Executive Officer | Feb 12 | Open-market buy · P | +29,500 | $0.84 | +$24.8K | 109,000 |
| Look Kirk | Chief Financial Officer | Feb 12 | Open-market buy · P | +12,000 | $0.84 | +$10.1K | 287,515 |
| Seizinger Bernd R. | Director | Feb 12 | Open-market buy · P | +40,000 | $0.85 | +$33.9K | 566,991 |
| Pisano Wayne | Director | Feb 12 | Open-market buy · P | +30,000 | $0.84 | +$25.3K | 492,414 |
| Aromando Andrew | Chief Business Officer | Feb 11 | Open-market buy · P | +29,600 | $0.86 | +$25.4K | 55,100 |
| Kelly Jared | Chief Executive Officer | Feb 11 | Open-market buy · P | +5,600 | $0.84 | +$4.68K | 79,500 |
| Seizinger Bernd R. | Director | Feb 11 | Open-market buy · P | +60,000 | $0.83 | +$49.6K | 526,991 |
| Seizinger Bernd R. | Director | Jan 16 | Open-market buy · P | +100,000 | $1.04 | +$104K | 466,991 |
Loading...